this is an outdated text: switch to the updated & improved dc code website
home, about

The DC Code: § 3-1202.08 Board of Pharmacy.

Index3 District of Columbia Boards and Commissions. (Refs & Annos)
There is established a Board of Pharmacy to consist of 7 members appointed by the Mayor.
(1) The Board shall regulate the practice of pharmacy and the practice of pharmaceutical detailing.
The Board is authorized to:
Establish a code of ethics for the practice of pharmaceutical detailing; and
Collect information from licensed pharmaceutical detailers relating to their communications with licensed health professionals, or with employees or representatives of licensed health professionals, located in the District.
Of the members of the Board, 5 shall be pharmacists licensed in the District and 2 shall be consumer members.
Except as provided in subsection (e) of this section, members of the Board shall be appointed for terms of 3 years.
Of the members initially appointed under this section, 2 shall be appointed for a term of 1 year, 2 shall be appointed for a term of 2 years, and 3 shall be appointed for a term of 3 years.
An individual licensed to practice pharmacy pursuant to this chapter may administer immunizations and vaccinations only if certified to do so by the Board and only pursuant to a written protocol and valid prescription or standing order of a physician.
The Board and the Board of Medicine shall jointly develop and promulgate regulations to implement and regulate the administration of vaccinations and immunizations by pharmacists and to authorize pharmacists certified to administer vaccinations and immunizations to administer emergency anaphylactic reaction treatment pursuant to an approved physician-pharmacist protocol.
(1) A licensed pharmacist may initiate, modify, or discontinue a drug therapy regimen pursuant to a collaborative practice agreement with a licensed physician, or, pursuant to § 3-1204.12, other health practitioner.
The Board and the Board of Medicine shall jointly develop and issue regulations governing the implementation and use of collaborative practice agreements between a licensed pharmacist and a licensed physician. At minimum, the regulations shall:
Require that all collaborative practice agreements include:
Specification of the drug therapy to be provided and any tests that may be necessarily incident to its provision;
The conditions for initiating, modifying, or discontinuing a drug therapy; and
Directions concerning the monitoring of a drug therapy, including the conditions that would warrant a modification to the dose, dosage regime, or dosage form of the drug therapy; and
Establish policies and procedures for approving, disapproving, and revoking collaborative practice agreements.

Historical and Statutory

Prior Codifications 1981 Ed., § 2-3302.8. Effect of Amendments D.C. Law 17-131 rewrote subsec. (b), which had read as follows: "(b) The Board shall regulate the practice of pharmacy." D.C. Law 17-306 added subsecs. (f) and (g). D.C. Law 19-185 added subsec. (h). Emergency Act Amendments For temporary (90 day) amendment of section, see § 2(b) of Pharmacy Practice Emergency Amendment Act of 2008 (D.C. Act 17-596, December 8, 2008, 55 DCR 12816). For temporary (90 day) amendment of section, see § 2(b) of Pharmacy Practice Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-29, March 16, 2009, 56 DCR 2323). Legislative History of Laws For legislative history of D.C. Law 6-99, see Historical and Statutory Notes following § 3-1201.01. For Law 17-131, see notes following § 3-1201.02. For Law 17-306, see notes following § 3-1201.02. For history of Law 19-185, see notes under § 3-1201.02. DC CODE § 3-1202.08 Current through December 11, 2012


(Mar. 25, 1986, D.C. Law 6-99, § 208, 33 DCR 729; Mar. 26, 2008, D.C. Law 17-131, § 102(c), 55 DCR 1659; Mar. 20, 2009, D.C. Law 17-306, § 2(b), 56 DCR 23; Oct. 22, 2012, D.C. Law 19-185, § 2(b), 59 DCR 9454.)